By Gusty Thursday, 30 July 2015 CHF clinical trials Entresto evidence-based medicine manipulating clinical research Novartis sacubitril Good Health and Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year. Elvonda The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an eleva...